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We conducted a population-based retrospective cohort study among 179398 Swedish patients hospitalised for alcoholism from
1970 to 1994, and found no excess risk for colorectal cancers, overall or at any anatomical subsite. Our findings challenge the
hypothesis that alcohol intake is a risk factor for cancer of the large bowel.
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A role of alcohol in the aetiology of colorectal cancer has long been
suspected. However, epidemiological data, as summarised in two
reviews (Kune and Vitetta, 1992; Potter, 1999), are conflicting, both
with regard to the existence of such an association and to possible
variations by anatomical subsites. The disagreement continues in
subsequent studies (Gerhardsson de Verdier et al, 1993; Goldbohm
et al, 1994; Glynn et al, 1996b; Le Marchand et al, 1997; Hsing et al,
1998; Munoz et al, 1998; Tavani et al, 1998; Nagata et al, 1999;
Sharpe et al, 2002). For experimental colon cancer, the tumorigen-
esis in the right and left colon was affected differently by the level
of alcohol consumed (Seitz et al, 1998).
If alcohol is indeed a risk factor for colorectal cancer, this
association should be easiest to document among subjects with a
high and long-term intake, such as alcoholics. However, previous
studies of alcoholics have not been large enough to generate stable
relative risk estimates by subsite. Moreover, the follow-up time has
generally been short or incomplete (Hakulinen et al, 1974; Monson
and Lyon, 1975; Robinette et al, 1979; Schmidt and Popham, 1981;
Adami et al, 1992; Tonnesen et al, 1994; Sigvardsson et al, 1996)
We therefore conducted a large nationwide retrospective cohort
study, based on the Swedish Inpatient Register, to quantify the risk
of colorectal cancer among patients hospitalised at least once with
a diagnosis of alcoholism.
PATIENTS AND METHODS
This record-linkage study was based on the Swedish Inpatient
Register created by the National Board of Health and Welfare and
described in detail elsewhere (Nyren et al, 1995). In brief, the
register contains administrative and medical data such as hospital
department and discharge diagnoses. Ascertainment of cancer
incidence was achieved by linkage to the more than 98% complete
Swedish Cancer Register, which used the ICD-7 classification
throughout the study period. As a separate code for cancer of the
anus (ICD7 code 154.1) was first introduced in 1970, our study
period began in 1970, rather than 1965 when the Inpatient Register
was started.
We identified 193040 discharge records in the Inpatient Register
with a diagnosis of alcoholism (ICD-8¼291, 303; ICD-9¼291, 303,
305A) during 1970–1994. Record linkage to the nationwide
Register of Causes of Death allowed us to identify deaths among
the study cohort through 1995. Corresponding linkage to the
Emigration Register identified dates of emigration. To remove
records with incorrect national registration numbers, which would
otherwise contribute person-years at no risk of cancer, we also
linked the cohort file to the Register of the Total Population. If a
national registration number could not be traced in this register, or
in the reports of death and emigration, it was deemed to be of
erroneous or incomplete numbers and thus excluded (7425
records). We also excluded 3348 patients with prevalent cancers,
since our analysis concerns first primary cancer only. We further
excluded 2136 patients who died during the hospitalisation for
alcoholism and 733 patients with inconsistencies uncovered during
record linkage. Thus, a total of 179398 patients, 36568 women and
142830 men, were entered into the study cohort.
Since the likelihood of being hospitalised for alcoholism may
increase if there are also insidious symptoms of a yet undetected
cancer, we excluded the first year of follow-up in our study. Thus,
follow-up time (person-years) was calculated 1 year after the first
recorded (index) hospitalisation for alcoholism until the occur-
rence of a first cancer diagnosis, emigration, death, or the end of
the observation period (31 December 1995), whichever occurred
first. To avoid possible ascertainment bias caused by differential
autopsy rates, we did not count cancers found incidentally at
autopsy. The expected number of cancers was calculated by
multiplying the observed number of person-years in age- (in 5-
year groups), gender-, and calendar-year-specific strata by the
corresponding cancer incidence rates, derived from the entire
Swedish population (Ye et al, 2001). Relative risk was estimated as
the standardised incidence ratio (SIR), defined as the ratio of the
observed number of cancers to that expected. The 95% confidence
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observed number follows a Poisson distribution (Bailar and
Ederer, 1964).
No information was available on severity or duration of
alcoholism, nor on treatment given. However, we had information
on accompanying codiagnoses at the index or subsequent
admissions. Stratified analyses were performed on the presence
or absence of liver cirrhosis. Person-years before the first recorded
occurrence of an accompanying disease were allocated to the
comorbidity-negative strata. We also stratified the analyses by
selected cohort characteristics that may influence the results,
including gender and follow-up duration.
RESULTS
The mean age at index hospitalisation among the 179398
alcoholics (36568 women, 142830 men) was 45 years, and the
mean duration of follow-up was around 9 years, yielding a total of
1627902 person-years at risk (Table 1). Of these patients, 7236
(4.0%) had a codiagnosis of liver cirrhosis at least once during the
period up to 1 year before the end of observation.
Based on a total of 929 incident cancers of the colon or rectum
vs 931 expected, we did not observe any significant overall excess
risk of colorectal cancer during 1–25 years of observation
(SIR¼1.00, 95% CI, 0.93–1.06) (Table 2). When examined by
separate subsites, a lack of association was evident for colon
(SIR¼1.00), right-sided colon (SIR¼0.97), left-sided colon
(SIR¼0.96), and for rectal cancer (SIR¼0.99). Further stratifica-
tion by gender, follow-up duration and presence of liver cirrhosis
did not reveal any significant excess risk of colorectal cancer,
overall or at any anatomical subsite.
DISCUSSION
This is the largest cohort study to date on risk of colorectal cancer
among alcoholics. It enabled detailed analyses by anatomic
subsites. This study design offers a number of strengths, including
the reduction in potential recall bias. Further, the high quality of
Swedish national registers and the consistent use of the unique
national registration numbers assigned to each person ensure
correct linkage, thereby precluding selective loss to follow-up. One
potential concern is the possibility of biased ascertainment or
detection of the cancer outcome. A lower diagnostic coverage
among alcoholics than in the population at large would entail
underestimation of the true relative risk. However, the Swedish
health-care system, with low patient fees and equal access to
hospital care for everyone, helps allay this concern. Had under-
ascertainment of cancer morbidity been a general problem, we
would expect the overall cancer incidence to be low, but this was
not the case (data not shown).
Another concern is the lack of information about amount and
type of alcohol intake, duration of alcohol abuse before index
Table 1 Characterisitics of the alcoholism cohort in the Swedish Inpatient Register 1970–1994 followed
up during 1–25 years through 1995
Characteristics Total Women Men
No. of patients 179398 36568 142830
Mean age at entry (years) 45.0 43.2 45.5
Years of follow-up, mean 9.0 8.5 9.2
Person-years at risk 1627902 312777 1315125
With a codiagnosis of liver cirrhosis (percent) 7236 (4.0) 1714 (4.7) 5522 (3.9)
Table 2 Standardised incidence ratios (SIR) with 95% confidence interval (CI) for colorectal cancers among alcoholics, stratified by selected cohort
characteristics
a
Colon
Colon and rectum Total (ICD7: 153) Right-sided (ICD7: 153.0) Left-sided (ICD7: 153.1–153.3) Rectum (ICD7:154.0)
Cancer site O
b SIR 95% CI O
b SIR 95% CI O
b SIR 95% CI O
b SIR 95% CI O
b SIR 95% CI
Total 929 1.00 0.93–1.06 557 1.00 0.92–1.09 173 0.97 0.83–1.12 265 0.96 0.84–1.08 372 0.99 0.89–1.09
Gender
Male 805 1.02 0.95–1.09 470 1.02 0.93–1.11 143 0.96 0.81–1.13 227 0.98 0.85–1.11 335 1.02 0.91–1.13
Female 124 0.89 0.74–1.06 87 0.94 0.75–1.16 31 1.01 0.68–1.43 38 0.86 0.61–1.18 37 0.80 0.56–1.10
Duration of follow-up (years)
1–4 260 0.99 0.88–1.12 155 0.99 0.84–1.16 45 0.89 0.65–1.19 80 1.00 0.79–1.24 105 1.00 0.81–1.21
5–9 278 1.00 0.89–1.13 173 1.05 0.90–1.22 58 1.08 0.82–1.40 77 0.92 0.73–1.15 105 0.94 0.77–1.14
10–14 209 0.95 0.83–1.09 129 0.98 0.82–1.17 37 0.87 0.61–1.20 60 0.93 0.71–1.20 80 0.90 0.71–1.12
15–19 156 1.12 0.95–1.31 86 1.04 0.83–1.29 31 1.18 0.80–1.68 39 0.97 0.69–1.33 70 1.24 0.97–1.56
20+ 26 0.80 0.52–1.17 14 0.72 0.40–1.21 2 0.33 0.04–1.18 9 0.96 0.44–1.83 12 0.90 0.47–1.58
Liver cirrhosis
c
No 893 1.00 0.93–1.06 536 1.00 0.92–1.09 167 0.97 0.83–1.13 252 0.95 0.83–1.07 357 0.99 0.89–1.09
Yes 36 1.02 0.72–1.42 21 1.00 0.62–1.52 6 0.87 0.32–1.90 13 1.23 0.65–2.10 15 1.06 0.59–1.75
aThe first-year observation was excluded.
bObserved number of cases.
cPerson-years before the onset of liver cirrhosis were allocated to the liver cirrhosis-negative stratum.
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ment of dose–response relation, but it is unlikely to affect
seriously the overall association with colorectal cancer risk.
Imperfect specificity of the alcoholism diagnosis (a high false-
positive rate) could conceivably bias a true positive association
towards the null. However, the threshold for making an in-hospital
diagnosis of alcoholism is generally high. Patients registered with
this diagnosis in their case records mostly have a clearly
manifested disease. Therefore, the rate of false-positive alcoholism
diagnoses in the Swedish Inpatient Register is deemed to be low. A
high prevalence of alcoholism in the reference population might be
yet another source for underestimation of a true-positive
association with colorectal cancer risk. Admittedly, approximately
up to 10% of the Swedish adult population is estimated to have
problems with alcohol overconsumption (Mutzell et al, 1987; Spak
and Hallstrom, 1995), but the per capita consumption in Sweden is
lower than in most European and American countries (Ramstedt,
2001).
Our most serious concern is the absence of information about
cofactors possibly related both to alcoholism and to the cancer
outcome. Confounding from such cofactors, for example, smoking
(Giovannucci, 2001), low intake of vegetables and fruits (Potter,
1996), folate deficiency (Giovannucci et al, 1995b; Glynn et al,
1996a; Su and Arab, 2001), and physical activity (Giovannucci et al,
1995a), however, would rather tend to inflate the relative risk
estimates. We have been unable to identify any factor – except
possibly for use of aspirin that is conceivably high among
alcoholics and might protect from colon cancer (Thun et al,
1991) – that has the potential of introducing negative confounding.
We therefore conclude that our negative findings are unlikely to be
explained by bias or confounding.
In conclusion, our findings did not support an important role of
alcohol in the aetiology of colorectal cancer.
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